ALXN1850

ALXN1850 · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ALXN1850, covering 2024-12-27 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa [Phase 3]